Abstract:Background and aims: At the Fiumicino Rome Airport, passengers can undergo the antigen or molecular test for SARS-CoV-2 at the COVID-19 Test Area (CTA), in compliance with the boarding regulations on air flights and those for entering the destination countries. The aim of this study was to describe the adaptability and usefulness of using rapid molecular tests designed for point of care (POC) in a context such as the CTA of Rome Fiumicino airport, by describing the volume and activities performed in the last period of the state of emergency in Italy, July 10, 2021- March 31, 2022. Materials and methods: Rapid molecular tests for SARS-CoV-2 were carried out with ID NOWTM COVID-19 assay on the ID NOWTM platform using dry swabs collected from passengers (or airport staff) at the CTA. Swabs were stored at room temperature and analyzed within 1-2 hours of collection. Sequencing for SARS-CoV-2 variants of concern (VOC) identification was carried out on swabs dipped in universal transport medium (UTM), after new swab gathering from consenting passengers resulted positive with the rapid molecular assay. A proficiency panel prepared with the viral isolate 2019-nCoV/Italy INMI1 was used to evaluate analytical sensitivity; clinical sensitivity was tested by performing real-time polymerase chain reaction (RT-PCR) tests on 50 swabs obtained from passengers who previously resulted positive to ID NOWTM COVID-19 assay. Results: In total, 14632 rapid molecular tests for SARS-CoV-2 were performed at CTA and 5.6% resulted positive. Sequence analysis of samples with Ct value <25 (61,2 %) with real-time RT-PCR test allowed detection of all the main VOCs: B.1.617.2 (Delta) in 18% of samples, BA.1 (Omicron-1) in 34% of positive swabs and BA.2 (Omicron-2) lineage in 9% of samples. The BA.2 variant was detected in the Lazio region for the first time at CTA, in one sample obtained from an Italian passenger coming from Doha, Qatar. A proficiency panel for SARS-CoV-2 detection was used to establish the limit of detection of ID NOWTM COVID-19 assay. For clinical sensitivity evaluation, 50 subjects with positive results by ID NOWTM COVID-19 assay were tested with routine real-time RT-PCR method in the laboratory and confirmed for SARS-CoV-2 detection. Conclusions: The great success among passengers, demonstrated by the large number of rapid molecular tests performed, confirmed the appreciation of this service by the users. Our experience at CTA showed that airports, railways and maritime stations should represent strategic surveillance centers for monitoring of circulation of respiratory pathogens, and may have a direct impact on the implementation of prevention and control strategies for public health against the spreading of infectious diseases. Indeed, SARS-CoV-2 data obtained at the CTA faithfully reflected the Italian epidemic curve trend of SARS-CoV-2 and its variants. The rapid molecular ID NOWTM COVID-19 assay used at CTA has proven to be suitable for use in a special context, such as the Rome Fiumicino Airport, though it was designed for use in POC. Due to the simplicity of use, robustness of method and technology that allows the return of results in a few minutes, this system revealed itself to be an optimal tool at the CTA, ensuring passengers boarding on COVID-free flights in a short time and security.

SARS-CoV-2 Testing of Aircraft Wastewater Shows That Mandatory Tests and Vaccination Pass before Boarding Did Not Prevent Massive Importation of Omicron Variant into Europe

Detection of SARS-CoV-2 RNA in commercial passenger aircraft and cruise ship wastewater: a surveillance tool for assessing the presence of COVID-19 infected travellers

Suitability of aircraft wastewater for pathogen detection and public health surveillance

Detection of the Omicron (B.1.1.529) variant of SARS-CoV-2 in aircraft wastewater

Estimated Airline Compliance With Predeparture SARS-CoV-2 Testing for Passengers on Flights to the United States, January 2021 to June 2022

SARS-CoV-2 Prevalence on and Incidence after Arrival in Travelers on Direct Flights from Cape Town, South Africa to Munich, Germany Shortly after Occurrence of the Omicron Variant in November/December 2021: Results from the OMTRAIR Study

Usefulness of aircraft and airport wastewater for monitoring multiple pathogens including SARS-CoV-2 variants

Monitoring multi-pathogens and SARS-CoV-2 variants in aircraft and airport wastewater

Long-term wastewater monitoring of SARS-CoV-2 viral loads and variants at the major international passenger hub Amsterdam Schiphol Airport: A valuable addition to COVID-19 surveillance

Reprint of: Air travel and COVID-19 prevention in the pandemic and peri-pandemic period: A narrative review

Passengers screening for SARS-CoV-2 infection at Rome Fiumicino Airport: a strategy aimed at limiting the spreading of the infection through COVID-free air flights revealed the airport role as a formidable sentinel center for monitoring pandemic trends and viral variants circulation

Risk of symptomatic COVID-19 due to aircraft transmission: a retrospective cohort study of contact-traced flights during England's containment phase

Air travel and COVID-19 prevention in the pandemic and peri-pandemic period: A narrative review

Feasibility of wastewater-based detection of emergent pandemics through a global network of airports

Detection of SARS-CoV-2 Variants Imported Through Land Borders at the Height of the COVID-19 Pandemic in Ghana, 2022

Use of wastewater from passenger ships to assess the movement of COVID-19 and other pathogenic viruses across maritime international boundaries

Metagenomic analysis of viruses in toilet waste from long distance flights-A new procedure for global infectious disease surveillance

Genomic surveillance of Canadian airport wastewater samples allows early detection of emerging SARS-CoV-2 lineages

A methodology for estimating SARS-CoV-2 importation risk by air travel into Canada between July and November 2021

Delusions of Certainty: Commercial Vessel COVID-19 Risk Stratification

Transmission of SARS-CoV-2 on aircraft: A scoping review